Aktive Positionen von Naresh K. Nayyar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TURG POIN | General Counsel | 01.06.2018 | - |
Karriereverlauf von Naresh K. Nayyar
Ehemalige bekannte Positionen von Naresh K. Nayyar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01.04.2016 | 01.05.2018 |
Ausbildung von Naresh K. Nayyar
| University of Delhi | Doctorate Degree |
| University of Phoenix | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Indien | 2 |
Operativ
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Naresh K. Nayyar
- Erfahrung